Join
Live feed
·
INSIDERFilingvia Quantisnow
NGM Biopharmaceuticals Inc. logo

SEC Form 4: Column Group L P bought $201,588 worth of shares (40,327 units at $5.00)

ByQuantisnow·Wall Street's wire, on your screen.
NGM· NGM Biopharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NGM (NGM Biopharmaceuticals Inc.) and more on Quantisnow.